
Join to view full profile
1161 21st Ave S# A-0118Nashville, TN 37232
Phone+1 615-936-0060
Fax+1 615-936-0223
Dr. Fu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cary Fu is a Child Neurologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 12 years. He is experienced in pediatric epilepsy, general child neurology and Rett syndrome.
Education & Training
Vanderbilt University Medical CenterFellowship, Clinical Neurophysiology, 2008 - 2009
University of Alabama Hospital (Birmingham)Fellowship, Child Neurology, 2005 - 2008
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2002 - 2005
University of Missouri-Columbia School of MedicineClass of 2002
Certifications & Licensure
TN State Medical License 2009 - 2028
AL State Medical License 2005 - 2020
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
Publications & Presentations
PubMed
- 3 citationsMedical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 Variants.Talia Thompson, Dennis Gurfinkel, Lori Silveira, Natalia Klamut, Kate Ferdinandsen
American Journal of Medical Genetics. Part A. 2025-10-01 - 8 citationsResults from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndrome.Alan K Percy, Robin Ryther, Eric D Marsh, Jeffrey L Neul, Timothy A Benke
Med. 2025-06-13 - 5 citationsA randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome.Kathleen Campbell, Jeffrey L Neul, David N Lieberman, Elizabeth Berry-Kravis, Tim A Benke
Journal of Neurodevelopmental Disorders. 2025-01-24
Press Mentions
- Potential Rett Syndrome Drug Shows Promising Results in Phase 3 TrialDecember 6th, 2021
- Rett Syndrome Drug Studied at Vanderbilt Approved for PatientsJuly 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: